Brand Name_Justification FORM) Covidien-Medtronic.pdf

BRAND NAME OR EQUAL

JUSTIFICATION AND APPROVAL

Purchase Request No: N0025921RCD___________________ Department: DSS/ MAIN OPERATING ROOM POC/Tel. No.: (619) 532-5487 Proposed Vendor: COVIDIEN

IAW FAR 13.106(1)(b)

1. Description of the supplies and/or services required to meet the end-user’s minimum needs :

The Main Operating Room (MOR) is requesting to purchase directly from Covidien as required items for basic cases utilizing electrosurgical cautery and tissue dissection that can only be procured through direct purchase currently. The requested items include the Ligasure device for both laparoscopic and open general Surgery, Urology and OB/GYN cases.

2. Estimated value of the requirement:

$250,000

3. Contractor’s unique qualifications which make him/her the ONLY source that can truly satisfy the Government’s minimum requirements:

Covidien is the only manufacturer of Endoscopic and open Ligasure devices which are a surgical staple in the MOR. They are not available through our Prime Vendor or Covidien DAPA Contract.

4. Demonstration of the market search conducted appropriate to the size and complexity of the Government’s minimum requirements. Include sources (in Government and industry) contacted and information obtained per source which further supports a sole source acquisition request.:

Covidien/Medtronic is the source that our PVM, Cardinal health has directed us to purchase directly from for the immediate future. Covidien is also the only manufacturer of the Ligasure® cautery device, which has been adopted as a staple across many surgical services and current surgical technique relies upon. Covidien/Medtronic will continue to be carried by PVM as some catalog items are still available through PVM. Only Covidien/Medtronic was contacted for price quotation.

5. Other facts supporting the use of other than full and open competition:

Purchasing other electrocautery/electrosurgery consumables would require the purchase or rental of the manufacturer’s proprietary equipment to utilize them; which would prove to be neither expedient nor cost-effective. Delaying the MORs ability to support the performance of these types of cases will result in delayed surgical intervention, worsening of (Rev 3/3/16)

(Rev 3/3/16) patient condition, disengagement to network and/or lowered patient satisfaction.

6. Statement of the actions that are being taken to remove or overcome any barriers to competition:

As Covidien/Medtronic will continue to be carried by PVM, we will continue to purchase through PVM. Continuous market research will be conducted to ensure these are the best products available to work with the existing electrosurgery equipment. Market research will also be conducted before purchase of any replacement electrosurgery equipment.

Signature of Director/Chairman/Department Head Date

CONTRACTING OFFICER APPROVAL SIGNATURE

_____Approved _____ Disapproved

Comments: __________________________________________________________________________________

Signature/Date

CONTRACTING OFFICER APPROVAL SIGNATURE